Brief: Amniotics Granted U.S. Patent For Pulmostem

Amniotics AB (publ)

10/08/2022 08:06

Aug 10 (Reuters) - Amniotics AB (publ)  AMNI.ST :
    * AMNIOTICS GRANTED KEY U.S. PATENT FOR PULMOSTEM™
    * THIS NEWLY ALLOWED U.S. PATENT PROVIDES AMNIOTICS WITH
EXCLUSIVE
COMMERCIAL RIGHTS IN U.S. AT LEAST UNTIL 2040 FOR USE OF
AMNIOTIC DERIVED STEM CELL PRODUCT PULMOSTEM™ IN TREATMENT OF
ACUTE RESPIRATORY DISTRESS SYNDROME

Source text for Eikon:  ID:nMFN4qjJzS 
Further company coverage:  AMNI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))